Primary malignant melanoma of the vulva: An aggressive tumor for modeling the genesis of non-UV light-associated melanomas

Acta Oncologica

Volumn 43, Issue 5, 2004, Pages 421-435

  Ragnarsson Olding, Boel K ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

BODY DISTRIBUTION; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL FEATURE; COMPARATIVE STUDY; GLABROUS SKIN; HISTOPATHOLOGY; HUMAN; INCIDENCE; MELANOMA; MOLECULAR GENETICS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; ULCER; ULTRAVIOLET RADIATION; VULVA; VULVA CANCER; VULVA TUMOR; VULVECTOMY;

FEMALE; HUMANS; MELANOMA; NEOPLASMS, RADIATION-INDUCED; PROGNOSIS; SKIN NEOPLASMS; ULTRAVIOLET RAYS; VULVAR NEOPLASMS;

EID: 3843087203     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860410031372     Document Type: Review

References (124)

1. Ragnarsson-Olding B, Johansson H, Rutqvist LE, Ringborg U. Malignant melanoma of the vulva and vagina: trends in incidence, age distribution and long-term survival among 245 consecutive cases in Sweden 1960-1984. Cancer 1993; 71: 1893-7.
2. Weinstock MA. Malignant melanoma of the vulva and vagina in the United States: patterns of incidence and population-based estimates of survival. Am J Obstet Gynecol 1994; 171: 1225-30.
3. Ragnarsson-Olding BK, Kanter-Lewensohn LR, Lagerlöf B, Nilsson BR, Ringborg UK. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish female: clinical observations and histopathological features. Cancer 1999; 86: 1273-84.
4. Burke TW, Eifel P, McGuire W, Wilkinson EJ. Vulva. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and practice of gynecological oncology, 2nd edn. Philadelphia: Lippincott-Raven; 1997. p. 717-51.
5. Pierson KK. Malignant melanomas and pigmented lesions of the vulva. In: Wilkinson EJ, ed. Pathology of the vulva and vagina. New York: Churchill Livingstone; 1987. p. 155-79.
6. Mattsson B, Rutqvist L, Wallgren A. Undernotification of diagnosed cancer cases to the Stockholm Cancer Registry. Int J Epidemiol 1985; 14: 64-9.
7. The Swedish National Cancer Registry. Cancer incidence in Sweden 1960-1999. Stockholm: National Board of Health and Welfare, Centre for Epidemiology.
8. Gillgren P, Månsson-Brahme E, Frisell J, Johansson H, Larsson O, Ringborg U. Epidemiological characteristics of cutaneous malignant melanoma of the head and neck: a population-based study. Acta Oncol 1999; 38: 1069-74.
9. Cullen W, Carswell R. On melanosis. Tr Med Chir Soc Edinburgh 1824: 264.
10. Hewett P. Melanosis of the labium and glands of the groin and pubes. Lancet 1861; 1: 263.
11. Ragnarsson-Olding B. Malignant melanoma of the vulva [Doctoral Thesis]. Stockholm: Karolinska Institute; 1999. Free copy on request.
12. Morrow CP, Rutledge FN. Melanoma of the vulva. Obstet Gynecol 1972; 39: 745-52.
13. Chang A, Karnell LH, Menck HR. The national cancer data base report on cutaneous and noncutaneous melanoma. Cancer 1998; 83: 1664-78.
14. Creasman WT, Phillips JL, Menck HR. A survey of hospital management practices for vulvar melanoma. J Am Coll Surg 1999; 188: 670-5.
15. Thörn M, Adami H-O, Bergström R, Ringborg U, Krusemo U. Trends in survival from malignant melanoma: remarkable improvement in 25 years. J Natl Cancer Inst 1989; 81: 611-7.
16. Bradgate MG, Rollason TP, McConkey CC, Powell J. Malignant melanoma of the vulva: a clinico-pathological study of 50 women. Br J Obstet Gynaecol 1990; 97: 124-33.
17. Scherstroen M, Tropé C, Kaern J, Pettersen EO, Abeler VM, Kristensen GB. Malignant melanoma of the vulva: evaluation of prognostic factors with emphasis on DNA ploidy in 75 patients. Cancer 1995; 75: 72-80.
18. DeMatos P, Tyler D, Seigler HF. Mucosal melanoma of the female genitalia: a clinicopathologic study of forty-three cases at Duke University Medical Center. Surgery 1998; 124: 38-48.
19. Räber G, Mempel V, Jackish C, Hundeiker M, Heinecke A, Kürzl R, Glaubitz M, Rompel R, Schneider HPG Malignant melanoma of the vulva: report of 89 patients. Cancer 1996; 78: 2353-8.
20. Verschraegen C, Benjapibal M, Suprakarapongkul W, Levy L, Ross M, Atkinson E, Bodurka-Bevers D, Kavanagh J, Kudelka A, Legha S. Vulvar melanoma at the M.D. Anderson Cancer Center: 25 years later. Int J Gynecol Cancer 2001; 11: 359-64.
21. Jaramillo BA, Ganjei P, Averette HE, Sevin B-U, Lovecchio JL. Malignant melanoma of the vulva. Obstet Gynecol 1985; 66: 398-401.
22. Edington PT. Monaghan JM. Malignant melanoma of the vulva and vagina. Br J Obstet Gynecol 1980; 87: 422-4.
23. Look KY, Roth LM, Sutton GP. Vulvar melanoma reconsidered. Cancer 1993; 72: 143-6.
24. Piura B, Egan M, Lopes A, Monaghan JM. Malignant melanoma of the vulva: a clinicopathologic study of 18 cases. J Surg Oncol 1992; 50: 234-40.
25. Johnson TL, Kumar NB, White CD, Morley GW Prognostic features of vulvar melanoma: a clinicopathologic analysis. Int J Gynecol Pathol 1986; 5: 110-8.
26. Karlén JR, Piver MS, Barlow JJ. Melanoma of the vulva. Obstet Gynecol 1975; 45: 181-5.
27. Yackel DB, Symmonds RE, Kempers RD. Melanoma of the vulva. Obstet Gynecol 1970; 35: 625-31.
28. Chung AF, Woodruff JM, Lewis JL, Jr. Malignant melanoma of the vulva: a report of 44 cases. Obstet Gynecol 1975; 45: 638-46.
29. Woolcott R, Henry RJV, Houghton CRS. Malignant melanoma of the vulva: Australian experience. J Repr Med 1988; 33: 699-702.
30. Allen AC, Spitz S. Malignant melanoma: a clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer 1953; 61: 1-45.
31. Balch CM, Buzaid AC, Soong S, Atkins M, Cascinelli N, Coit D, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 3635-48.
32. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172: 902-8.
33. Clark WH, Jr, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behaviour of primary human malignant melanoma of the skin. Cancer Res 1969; 29: 705-27.
34. Trimble EL, Lewis JL, Williams LL, Curtin JP, Chapman D, Woodruff JM, Rubin SC, Hoskins WJ. Management of vulvar melanoma. Gynecol Oncol 1992; 45: 254-8.
35. Goldsmith HS. Melanoma: an overview. C A Cancer J Clin 1979; 29: 194-215.
36. McNeer G, TK DG. Prognosis in malignant melanoma. Surgery 1964; 56: 512-8.
37. Ragnarsson-Olding BK, Nilsson BR, Kanter-Lewensohn LR, Lagerlöf B, Ringborg UK. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: predictors of survival. Cancer 1999; 86: 1285-93.
38. Wong T-Y, Ohara K, Kawashima M, Sober AJ, Nogita T, Mihm MCJ. Acral lentiginous melanoma (including in situ melanoma) arising in association with naevocellular naevi. Melanoma Res 1996; 6: 241-6.
39. Beahrs O, Henson DE, Hutter RVP, J KB, eds. American Joint Committee on Cancer. Manual for staging of cancer. 4th ed. Philadelphia: JB Lippincott; 1992.
40. Clark WJ, Elder D, van Horn M. The biological forms of malignant melanoma. Hum Pathol 1986; 17: 443-50.
41. Taran JM, Heenan PJ. Clinical and histological features of level 2 cutaneous malignant melanoma associated with metastasis. Cancer 2001; 91: 1822-5.
42. Benda JA, Platz CE, Anderson B. Malignant melanoma of the vulva: a clinical-pathologic review of 16 cases. Int J Gynecol Pathol 1986; 5: 202-16.
43. Rose PG, Piver MS, Tsukada Y, Lau T. Conservative therapy for melanoma of the vulva. Am J Obstet Gynecol 1988; 159: 52-5.
44. Tasseron EWK, Van der Esch EP, Hart AAM, Brutel de la Riviere G, Aartsen EJ. A clinicopathological study of 30 melanomas of the vulva. Gynecol Oncol 1992; 46: 170-5.
45. Cochran A, Bailly C, Eberhard P, Remotti F. Histology of common forms of cutaneous melanoma. In: Cochran A, Bailly C, Eberhard P, Remotti F, eds. Melanocytic tumors: a guide to diagnosis. Philadelphia/New York: Lippincott-Raven; 1997. p. 157-87.
46. Thörn M, Pontén F, Bergström R, Sparén P, Adami H-O. Trends in tumour characteristics and survival of malignant melanoma 1960-1984: A population-based study in Sweden. Br J Cancer 1994; 70: 743-8.
47. Ellwanger U, Garbe C. Recent epidemiological trends of cutaneous melanoma in Germany, Australia and Switzerland. Results of the Central Malignant Melanoma Registry. In: Altmeyer P, Hoffman K, Stucker M, eds. Skin cancer and UV radiation. Berlin: Springer; 1997. p. 507-18.
48. Balch CM, Soong S-J, Shaw HM, Maddox WA, Urist MM, McCarthy WH, Milton GW Changing trends in the clinical and pathologic features of melanoma. In: Soon S-J, ed. Cutaneous melanoma, 2nd edn. Philadelphia: JB Lippincott; 1992.
49. Reed RJ. New concepts in surgical pathology of the skin. New York: Wiley; 1976.
50. Arrington III JH, Reed RJ, Ichinose H, Krementz ET. Plantar lentiginous melanoma: a distinctive variant of human cutaneous malignant melanoma. Am J Surg Pathol 1977; 1: 131-43.
51. Elder DE. Skin cancer. Cancer 1995; 75: 245-56.
52. Ridgeway C, Hieken T, Ronan S, Kim D, Das Gupta T. Acral lentiginous melanoma. Arch Surg 1995; 130: 88-92.
53. Barnhill R, Mihm MJ. The histopathology of cutaneous malignant melanoma. Semin Diagn Pathol 1993; 10: 47-75.
54. Beattie CW, Tissot R, Amoss M. Experimental models in human melanoma research: a logical perspective. Semin Oncol 1988; 15: 500-11.
55. Muchmore JH, Krementz ET, Reed RJ, Carter RD, M SC. Melanoma of the hand and foot (volar and subungular melanoma). In: Balch Cm HA, Milton GW, Sober AJ, Soong S-J, eds. Cutaneous melanoma, 2nd edn. Philadelphia/New York: JB Lippincott; 1992. p. 234-63.
56. Clark WH Jr, Bernardino EA, Reed RJ, Kopf AW Acral lentiginous melanomas including melanomas of mucous membranes. In: Clark CJ, Goldman L, Mastrangelo M, eds. Human malignant melanoma. New York: Grune & Stratton; 1979. p. 55-108.
57. McGovern VJ. Melanocytic lesions of glabrous skin. In: McGovern V, ed. Melanoma: histological diagnosis and prognosis. New York: Raven Press; 1983. p. 125-37.
58. Bastian BC, Olshen AB, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 2003; 163: 1765-70.
59. Ackerman LV. Malignant melanoma of the skin: clinical and pathological analysis of 75 cases. Am J Clin Pathol 1948; 18: 602-24.
60. Crucioli V, Stilwell J. The histogenesis of malignant melanoma in relation to pre-existing pigmented lesions. J Cutaneous Pathol 1982; 9: 396-404.
61. Gruber SB, Barnhill RC, Stenn KS, Roush GC. Nevomelanocytic proliferations in association with cutaneous malignant melanoma: a multivariate analysis. J Am Acad Dermatol 1989; 21: 773-80.
62. Blessing K, Kernohan N, Miller I, Al Nafussi A. Malignant melanoma of the vulva. Int J Gynecol Oncol 1991; 1: 81-7.
63. Clark WH Jr, Hood AF, Tucker MA, Jampel RM. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia. Hum Pathol 1998; 29: S1-S24.
64. Nordlund JJ. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortone J-P, eds. The pigmentary system: physiology and pathophysiology. New York: Oxford University Press; 1998.
65. Okoro AN. Albinism in Nigeria. Br J Dermatol 1975; 92: 485-92.
66. Luande J, Henschke CJ, Mohammed N. The Tanzanian albino skin natural history. Cancer 1985; 55: 1823-8.
67. Ihn H, Nakamura K, Abe M, Furue M, Takehara K, Nakagawa H, Ishibashi Y Amelanotic metastatic melanoma in a patient with oculocutaneous albinism. J Am Acad Dermatol 1993; 5: 895-900.
68. Levine EA, Ronan SG, Shirali SS, Das Gupta TK. Malignant melanoma in a child with oculocutaneous albinism. J Surg Oncol 1992; 51: 138-42.
69. Casswell AG, McCartney AC, Hungerford JL. Choroidal malignant melanoma in an albino. Br J Ophthalmol 1989; 73: 840-5.
70. Garrington GE, Scofield HH, Cornyn J, Lacy GR. Intraoral malignant melanoma in a human albino. Oral Surg Oral Med Oral Pathol 1967; 24: 224-30.
71. Kheterpal S, Shields JA, Shields CL, De Potter P, Ehya H, Eng KY. Choroidal melanoma in an African-American albino. Am J Ophtalmol 1996; 122: 901-3.
72. Malaguarnera M, Romano M, Pistone G. Metastatic melanoma of the nasal cavity in a patient with oculocutaneous albinism. Clin Oncol (R Coll Radiol) 1998; 10: 404-6.
73. Larsson BS. The toxicology and pharmacology of melanins. In: Nordlund JJ, ed. The pigmentary system. New York: Oxford Univ; 1998. p. 373-99.
74. Dayhaw-Barker P. Retinal pigment epithelium melanin and ocular toxicity. Int J Toxicol 2002; 21: 451-4.
75. Norris W. Case of fungoid disease. Edinburgh Med Surg J 1820; 16: 562.
76. Thörn M, Pontén F, Bergström R, Sparén P, Adami H-O. Clinical and histopathological predictors of survival of malignant melanoma: a population-based study in Sweden. J Natl Cancer Inst 1994; 86: 761-9.
77. Balch CM, Cascinelli N, Drzewiecki KT, Eld J, Mackie RN, McCarthy WH, McLeod GR, Morton D, Seigler HF, Shaw HM, Sim FH, Sober AJ, Soong S-J, Takematsu H, Tonak J, Wong J. A comparison of prognostic factors worldwide. In: Balch C, Houghton AN, Milton GW, Sober AJ, Soong S-J, eds. Cutaneous melanoma, 2nd edn. Philadelphia: JB Lippincott; 1992. p. 188-99.
78. Scherstroen M, Tropé C, Kaern J, Abeler VM, Pettersen EO, Kristensen GB. Malignant melanoma of the vulva FIGO stage I: evaluation of prognostic factors in 43 patients with emphasis on DNA ploidy and surgical treatment. Gynecol Oncol 1996; 61: 253-8.
79. Phillips GL, Bundy BN, Okagaki T, Kucera PR, Stehman F. Malignant melanoma of the vulva treated by radical hemivulvectomy: a prospective study of the gynecologic oncology group. Cancer 1994; 73: 2626-32.
80. Balch C, Soong S-J, Gershenwald J, Thompson J, Reintgen D, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 16: 3622-34.
81. McGovern VJ. Prognostic significance of histological features of malignant melanoma. In: McGovern VJ, ed. Melanoma: histological diagnosis and prognosis. New York: Raven Press; 1982. p. 158-74.
82. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo W-L, Chen C, Ye Z, Dairkee SH, Ljung B-M, Gray JW Albertson DG. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nature Genetics 1998; 20: 207-11.
83. Van Dijk M, Sprenger S, Rombout P, Marres H, Kaanders J, Jeuken J, Ruite D. Distinct chromosomal aberrations in sinonasal mucosal melanoma as detected by comparative hybridization. Genes. Chromosom Cancer 2003; 36: 151-8.
84. Bastian B, Patel H, Busam K, Kageshita T, Kutzner H, Aiba S, Ueda M, Tokayasu T, Jain A, Pinkel D. Classifying melanoma based on DNA copy number changes using array-based comparative genomic hybridization. Pigment Cell Res 2002; 15(Suppl 9): 53.
85. Bastian BC, Kashani-Sabet M, Hamm H, Godfrey T, Moore DH, Bröcker E-B, LeBoit PE, Pinkel D. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res 2000; 60: 1968-73.
86. Micci Francesca TMR, Scherstroen Marit, Abeler Vera M, Heim Sverre. Cytogenetic characterization of tumors of the vulva and vagina. Genes, Chromosom Cancer 2003; 38: 137-48.
87. Jiveskog S, Ragnarsson-Olding B, Platz A, Ringborg U. N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin. J Invest Dermatol 1998; 111: 757-61.
88. Ragnarsson-Olding BK, Karsberg S, Platz A, Ringborg UK. Mutations in the TP53 gene in human malignant melanomas derived from sun-exposed skin and unexposed mucosal membranes. Melanoma Res 2002; 12: 453-63.
89. Carr J, Mackie R. Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi. Br J Dermatol 1994; 131: 72-7.
90. Ball NJ, Yohn JJ, Morelli JG, Norris DA, Golitz LE, Hoeffler JP. Ras mutations in human melanoma: a marker of malignant progression. J Invest Dermatol 1994; 102: 285-90.
91. Platz A, Sevigny P, Norberg T, Ring P, Lagerlöf B, Ringborg U. Genes involved in cell cycle G1 checkpoint control are frequently mutated in human melanoma metastases. Br J Cancer 1996; 74: 936-41.
92. Van Elsas A, Zerp SF, van der Flier S, Krüse KM, Aarnoudse C, Hayward NK, Ruiter DJ, Schrier PI. Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. Am J Pathol 1996; 149: 883-93.
93. Van't Veer LJ, Burgering BMT, Versteeg R, Boot AJM, Ruiter DJ, Osanto S, Schrier PI, Bos JL. N-ras mutations in human cutaneous melanoma from sun-exposed body sites. Mol Cell Biol 1989; 9: 3114-6.
94. Lubbe J, Reichel M, Burg G, Kleihues P. Absence of p53 gene mutations in cutaneous melanoma. J Invest Dermatol 1994; 102: 819-21.
95. Zerp SF, van Elsas A, Peltenburg L, Schrier PI. p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanoma genesis. Br J Cancer 1999; 79: 921-6.
96. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Pontén J. A role for sun-light in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991; 88: 10124-8.
97. Ouhtit A, Nakazawa H, Armstrong BK, Kricker A, Tan E, Yamasaki H, English DR. UV-radiation-specific p53 mutation frequency in normal skin as a predictor of risk of basal cell carcinoma. J Natl Cancer Inst 1998; 90: 523-31.
98. Podratz KC, Gaffey TA, Symmonds RE, Johansen KL, O'Brien PC. Melanoma of the vulva: an update. Gynecol Oncol 1983; 16: 153-68.
99. Cascinelli N. Surgical margins for thin melanomas. Melanoma Letter 1992; 10: 2.
100. Veronesi U, Cascinelli N, Adamus J, Balch C, Bandiera D, Barschuk A, et al. Thin grade I primary cutaneous malignant melanoma: comparison of excision with margins of 1 or 3 cm. N Engl J Med 1988; 318: 1159-62.
101. Ringborg U, Andersson R, Eldh J, Glaumann B, Hafström LO, Jacobsson S, et al. Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with tumor thickness of 0.8 to 2.0 mm. Cancer 1996; 77: 1809-14.
102. Neven P, Shepherd JH, Masotina A, Fisher C, Lowe DG. Malignant melanoma of the vulva and vagina: a report of 23 cases presenting in a 10-year period. Int J Gynecol Cancer 1994; 4: 379-83.
103. Veronesi U, Adamus J, Bandoera DC, Brennhovd IO, Caceres E, Cascinelli N. Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med 1977; 297: 627-30.
104. Morton D, Wen D-R, Wong J, Economou J, Cagle L, Storm F, Foshag L, Cochran A. Technical details of intraoperative mapping for early stage melanoma. Arch Surg 1992; 127: 392-9.
105. Abramova L, Parekh J, Irvin WPJ, Rice LW, Taylor PTJ, Anderson WA, Slingluff CLJ. Sentinel node biopsy in vulvar and vaginal melanoma: presentation of six cases and a literature review. Ann Surg Oncol 2002; 9: 840-6.
106. Davidson T, Kissin M, Westbury G. Vulvo-vaginal melanoma: should radical surgery be abandoned? Br J Obstet Gynecol 1987; 94: 473-6.
107. Måsbäck A, Olsson H, Westerdahl J, Ingvar C, Jonsson K. Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review. Melanoma Res 2001; 11: 435-45.
108. Stadelmann W, Rapaport D, Soong S-J, Reintgen DS, Buzaid AC, Balch CM. Prognostic, clinical and pathological features. In: Balch C, Houghten A, Sober A, Soong S-J, eds. Cutaneous melanoma. St Louis: Quality Medical Publishing; 1998.
109. Clark WH Jr, Elder DE, Guerry DP, IV, Braitmen LE, Trick BJ, Schultz D, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989; 81: 1893-904.
110. Ronan SG, Han MC, DasGupta TK. Histologic prognostic indicators in cutaneous malignant melanoma. Semin Oncol 1988; 15: 558-68.
111. Månsson-Brahme E. Cutaneous malignant melanoma: aspects on prognostic factors and time-trends in a Swedish population [Doctoral Thesis]. Stockholm: Karolinska Institute; 2002.
112. Walker MJ, Beattie CW, Patel MK, Ronan SM, das Gupta TK. Estrogen receptor in malignant melanoma. J Clin Oncol 1987; 5: 1256-61.
113. Grin CM, Driscoll MS, Grant-Kels JM. The relationship of pregnancy, hormones and melanoma. Sem Cutaneous Med Surg 1998; 17: 167-71.
114. Friedrich Jr E, Wilkinson BA. The vulva. In: Blaustein A, ed. Pathology of the female genital tract. New York: Springer Verlag; 1984. p. 48-9.
115. Vavra N, Seiffert M, Czerwenka K, Pehamberger H, Kucera H, Weghaupt K. Melanome der Vulva. Bericht über 12 Fälle. Geburtsch u Frauenheilk 1991; 51: 379-82.
116. Baltzer J, Kurzl R, Lohe KJ, Zander J. Melanoma of the vulva. J Reprod Med 1986; 31: 825-7.
117. Cascinelli N, Di Re F, Lupi G, Balzarini GP. Malignant melanoma of the vulva. Cancer 1970; 56: 345-52.
118. Iversen K, Robins RE. Mucosal malignant melanomas. Am J Surg 1980; 139: 660-4.
119. Beller U, Demopoulos RJ, Beckman EM. Vulvovaginal melanoma: a clinicopathological study. J Reprod Med 1986; 31: 315-9.
120. Irvin WJ, Legallo R, Stoler M, Rice L, Taylor PJ, Andersen W. Vulvar melanoma: a retrospective analysis and literature review. Gynecol Oncol 2001; 83: 457-65.
121. Bouma J, Weening JJ, Elders A. Malignant melanoma of the vulva: report of 18 cases. Eur J Obstet Gynecol Reprod Biol 1982; 13: 237-51.
122. Raspagliesi Fransesco DA, Paladino Dario, Fontanelli Rosanna, Stefanen Bernardina, DiPalma Silvana, De Palo Giuseppe. Prognostic indicators in melanoma of the vulva. Ann Surg Oncol 2000; 7: 738-42.
123. Ariel IM. Malignant melanoma of the female genital system: a report of 48 patients and review of the literature. J Surg Oncol 1981; 16: 371-83.
124. Trimble EL. Melanomas of the vulva and vagina. Oncology 1996; 10: 1017-23.